NEW
Stock Screener with Intrinsic Value
Novo Nordisk A/S (NVO)
Last Price$78.7(5.3%)
Market Cap$350.5B
$39.3B
+26.2% YoY
$13.8B
+25.8% YoY
($2,672.6M)
Net Debt to FCF - (0.3x)
$9,793.1M
24.9% margin
NVO Income Statement
NVO Income Statement Overview
Crunching data... Almost there!
NVO Income statement key metrics
Crunching data... Almost there!
NVO Balance Sheet
NVO Balance Sheet Overview
Crunching data... Almost there!
NVO Balance Sheet Metrics
Crunching data... Almost there!
NVO Cash Flow Statement
NVO Cash Flow Statement Overview
Crunching data... Almost there!
NVO Cash Flow Statement key metrics
Crunching data... Almost there!
NVO Financials
Crunching data... Almost there!
FAQ
What is the Novo Nordisk A/S (NVO) revenue?
The Novo Nordisk A/S (NVO) revenue is $33.7B, reflecting a year-over-year (YoY) growth of +31.3% YoY.
What is the Novo Nordisk A/S (NVO) Net Income?
The Novo Nordisk A/S (NVO) Net Income is $12.1B, showcasing a YoY growth of +50.7% YoY.
What is Novo Nordisk A/S (NVO) net debt?
What is the Novo Nordisk A/S (NVO) Free Cash Flow (FCF)?
The Novo Nordisk A/S (NVO) Free Cash Flow (FCF) stands at $10.1B, accounting for a 30.1% margin.